Practice
Featured experience
Incora emerges from chapter 11
We advised an ad hoc group of secured noteholders in connection with Incora’s chapter 11 proceedings
Venture Global $1.75 billion IPO
We advised Venture Global on its IPO and NYSE listing
Interactive Brokers claims for domestic production activities deductions
We are representing Interactive Brokers
Advice to multiple companies on potential tax refunds under the Varian ruling
We are representing clients in refund claims
Orbia $1.1 billion notes offering
We advised Orbia on the investment-grade debt offering
Somnigroup International $953 million secondary offering
The shares are listed on the New York Stock Exchange
Middlesex Water $110 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
CytomX Therapeutics $100 million stock offering
The stock is listed on the Nasdaq Global Select Market
Bank of America $5 billion floating-rate and fixed-to-floating-rate notes
The investment-grade debt offering is based on the Secured Overnight Financing Rate
Bank of America $3 billion preferred stock offering
The company issued depositary shares representing interests in fixed-rate reset non-cumulative preferred stock
Auna $62.1 million senior secured notes offering
We advised Auna on the offering
Biogen $1.75 billion senior notes offering
The investment-grade notes are due 2031, 2035 and 2055
Primo Brands $1.5 billion secondary offering
The shares are listed on the New York Stock Exchange
Hertz $1.66 billion revolving credit facility maturity extension
We advised Hertz on the transactions